Robert S. Breuil
Plus aucun poste en cours
Fortune : 146 074 $ au 31/03/2024
Profil
Robert S.
Breuil worked as a Director of Corporate Planning, Analysis & Controller at ALZA Corp.
and as a Chief Financial Officer & VP of Corporate Development at Aerogen, Inc. from 2002 to 2005.
He then worked as a Chief Financial Officer & SVP of Finance at Codexis, Inc. from 2006 to 2009.
He later served as the Chief Financial Officer at Graybug Vision, Inc. and Corium International, Inc. from 2012 to 2019.
Prior to these roles, he worked as a Controller at ALZA Pharmaceuticals.
Breuil received his undergraduate degree from the United States Naval Academy in 1983 and his MBA from Stanford Graduate School of Business in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CALCIMEDICA, INC.
0,33% | 23/03/2023 | 35 114 ( 0,33% ) | 146 074 $ | 31/03/2024 |
Anciens postes connus de Robert S. Breuil
| Sociétés | Poste | Fin |
|---|---|---|
| CORIUM INTERNATIONAL INC | Director of Finance/CFO | 01/08/2019 |
| CODEXIS, INC. | Director of Finance/CFO | - |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Director of Finance/CFO | 01/01/2005 |
| CALCIMEDICA, INC. | Director of Finance/CFO | - |
| ALZA Pharmaceuticals | Comptroller/Controller/Auditor | - |
Formation de Robert S. Breuil
| United States Naval Academy | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CODEXIS, INC. | Process Industries |
| Entreprise privées | 5 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Aerogen, Inc.
Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
| ALZA Pharmaceuticals |
